Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Bullous Pemphigoid
100%
COVID-19
98%
Population-based Study
95%
Psoriasis
79%
Population-based Cohort Study
52%
Hidradenitis Suppurativa
52%
Retrospective Cohort Study
48%
Pemphigus
46%
Atopic Dermatitis
44%
95% Confidence Interval
39%
Pyoderma Gangrenosum
33%
Hospitalization
31%
Pemphigus Vulgaris
25%
Israel
23%
Alopecia Areata
23%
Population-based Case-control Study
22%
Adjusted Odds Ratio
21%
Autoimmune Bullous Disease
21%
Odds Ratio
20%
Control Subjects
20%
Psoriatic Patients
18%
Large Cohort Study
17%
Rheumatoid Arthritis
17%
Acne Keloidalis nuchae
16%
Dipeptidyl peptidase-4 (DPP-4)
16%
Adjusted Hazard Ratio
16%
Autoantibodies
15%
Schizophrenia
15%
Bidirectional Relationship
14%
Immunological Characteristics
14%
IgA Pemphigus
13%
Comorbid
12%
Systemic Corticosteroids
12%
Clinical Characteristics
12%
Vaccination
12%
Anti-BP180
12%
Comorbidity
12%
Epidermolysis Bullosa Acquisita
11%
Blister
11%
Multivariate Analysis
11%
Mucous Membrane Pemphigoid
11%
Solid Malignancies
11%
Infantile Hemangioma
11%
MRNA Vaccine
11%
Amyloidosis
11%
Treatment Outcome
11%
Observational Prospective Study
11%
Ankylosing Spondylitis
11%
Clinical Outcomes
9%
Hazard Ratio
9%
Medicine and Dentistry
COVID-19
68%
Bullous Pemphigoid
54%
Retrospective Cohort Study
38%
Case-Control Study
34%
Psoriasis
33%
Odds Ratio
32%
Atopic Dermatitis
31%
Comorbidity
30%
Hidradenitis Suppurativa
28%
Cohort Analysis
26%
Prospective Study
22%
Systematic Review
22%
Pyoderma gangrenosum
22%
Schizophrenia
22%
Diseases
21%
Autoimmunity
21%
Prevalence
20%
Bullous Disease
19%
Acne Keloidalis Nuchae
16%
Pemphigus
16%
Alopecia Areata
16%
Pemphigus vulgaris
15%
Cross Sectional Study
15%
Hazard Ratio
14%
Dermatosis
14%
Oral
13%
Thyroid Disease
12%
Biological Product
12%
Cicatricial Pemphigoid
11%
Lichen Planus
11%
Capillary Hemangioma
11%
Propranolol
11%
Logistic Regression Analysis
10%
Autoantibodies
10%
Pruritus
9%
Hyperthyroidism
8%
Hypothyroidism
8%
Cohort Effect
8%
Nephropathy
7%
Asthma
7%
Multivariate Analysis
7%
Morbidity
7%
IgA Pemphigus
6%
Rhinophyma
6%
Metabolic Syndrome
6%
Patient Referral
6%
Pediatrics
6%
Inflammatory Infiltrate
6%
Pemphigus foliaceus
6%
Treatment Option
6%
Immunology and Microbiology
Bullous Pemphigoid
87%
COVID-19
54%
Pemphigus
50%
Atopic Dermatitis
25%
Autoantibodies
22%
Prevalence
20%
Infection
19%
Infectious Disease
19%
Comorbidity
19%
Pemphigus vulgaris
18%
Hidradenitis Suppurativa
18%
Autoimmunity
17%
Alopecia Areata
17%
Inflammatory Arthritis
17%
Biological Product
13%
IgA Pemphigus
12%
Pemphigoid
11%
Amyloidosis
11%
Dipeptidyl Peptidase IV
11%
Ankylosing Spondylitis
11%
Cicatricial Pemphigoid
10%
Seropositivity
10%
Cohort Effect
9%
Immunoglobulin A
8%
Epidemiology
8%
TNF Inhibitor
8%
Autoantigen
8%
Neutrophil
7%
Rituximab
7%
Pemphigus foliaceus
7%
Allergic Rhinitis
6%
Ulcerative Colitis
6%
Lichen Planus
6%
Dermatomyositis
6%
Asthma
6%
Immunoglobulin M
5%
Clostridium Botulinum Type A
5%
Systemic Lupus Erythematosus
5%
Hypogammaglobulinemia
5%
Therapeutic Target
5%
Granulocyte
5%
Seborrhoeic Dermatitis
5%
Blister Fluid
5%
Red Blood Cell Distribution Width
5%
Rupatadine
5%
Leukocyte Activation
5%
Acantholysis
5%
Dermatitis
5%
Blood Level
5%
Polymyositis
5%